List of MacroGenics patents

Patents where

Current Assignee

Name

MacroGenics

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 8946387 FcγRIIB specific antibodies and methods of use thereof	Patent 8946387 was granted and assigned to MacroGenics on February, 2015 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8946387	February 3, 2015
‌ US Patent 8187593 FcγRIIB specific antibodies and methods of use thereof	Patent 8187593 was granted and assigned to MacroGenics on May, 2012 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8187593	May 29, 2012
‌ US Patent 11591400 B7-H3 directed antibody drug conjugates	Patent 11591400 was granted and assigned to MacroGenics on February, 2023 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	11591400	February 28, 2023
‌ US Patent 11459394 Bispecific binding molecules that are capable of binding CD137 and tumor antigens, and uses thereof	Patent 11459394 was granted and assigned to MacroGenics on October, 2022 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	11459394	October 4, 2022
‌ US Patent 7632497 Engineering Fc Antibody regions to confer effector function	Patent 7632497 was granted and assigned to MacroGenics on December, 2009 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	7632497	December 15, 2009
‌ US Patent 7355008 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 7355008 was granted and assigned to MacroGenics on April, 2008 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	7355008	April 8, 2008
‌ US Patent 9096877 Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use	Patent 9096877 was granted and assigned to MacroGenics on August, 2015 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	9096877	August 4, 2015
‌ US Patent 8652466 Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγR	Patent 8652466 was granted and assigned to MacroGenics on February, 2014 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8652466	February 18, 2014
‌ US Patent 8133982 FcγRIIB specific antibodies and methods of use thereof	Patent 8133982 was granted and assigned to MacroGenics on March, 2012 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8133982	March 13, 2012
‌ US Patent 10954301 Bispecific molecules having immunoreactivity with PD-1 and CTLA-4, and methods of use thereof	Patent 10954301 was granted and assigned to MacroGenics on March, 2021 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	10954301	March 23, 2021
‌ US Patent 11623959 PD-1-binding molecules and methods of use thereof	Patent 11623959 was granted and assigned to MacroGenics on April, 2023 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	11623959	April 11, 2023
‌ US Patent 10577422 PD-1-binding molecules and methods of use thereof	Patent 10577422 was granted and assigned to MacroGenics on March, 2020 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	10577422	March 3, 2020
‌ US Patent 8003774 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 8003774 was granted and assigned to MacroGenics on August, 2011 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8003774	August 23, 2011
‌ US Patent 9056906 Methods for the treatment of autoimmune disorders using immunosuppressive monoclonal antibodies with reduced toxicity	Patent 9056906 was granted and assigned to MacroGenics on June, 2015 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	9056906	June 16, 2015
‌ US Patent 8216574 Engineering Fc antibody regions to confer effector function	Patent 8216574 was granted and assigned to MacroGenics on July, 2012 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8216574	July 10, 2012
‌ US Patent 7960512 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 7960512 was granted and assigned to MacroGenics on June, 2011 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	7960512	June 14, 2011
‌ US Patent 8951517 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 8951517 was granted and assigned to MacroGenics on February, 2015 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	8951517	February 10, 2015
‌ US Patent 8217147 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 8217147 was granted and assigned to MacroGenics on July, 2012 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8217147	July 10, 2012
‌ US Patent 8445645 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 8445645 was granted and assigned to MacroGenics on May, 2013 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8445645	May 21, 2013
‌ US Patent 10093738 Covalent diabodies and uses thereof	Patent 10093738 was granted and assigned to MacroGenics on October, 2018 by the United States Patent and Trademark Office.	MacroGenics	MacroGenics	United States Patent and Trademark Office	10093738	October 9, 2018
‌ US Patent 7112439 Dual expression vector system for antibody expression in bacterial and mammalian cells	Patent 7112439 was granted and assigned to MacroGenics on September, 2006 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	7112439	September 26, 2006
‌ US Patent 8192737 Identification and engineering of antibodies with variant Fc regions and methods of using same	Patent 8192737 was granted and assigned to MacroGenics on June, 2012 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	8192737	June 5, 2012
‌ US Patent 9296816 Covalent diabodies and uses thereof	Patent 9296816 was granted and assigned to MacroGenics on March, 2016 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	9296816	March 29, 2016
‌ US Patent 7786270 Humanized FcγRIIB-specific antibodies and methods of use thereof	Patent 7786270 was granted and assigned to MacroGenics on August, 2010 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	7786270	August 31, 2010
‌ US Patent 9028815 Identification and engineering of antibodies with variant FC regions and methods of using same	Patent 9028815 was granted and assigned to MacroGenics on May, 2015 by the United States Patent and Trademark Office.		MacroGenics	United States Patent and Trademark Office	9028815	May 12, 2015

...

Results per page:

113 results

0 selected

113 results

0 selected